Chelsea Counsel Company’s Bristol-Myers Squibb BMY Stock Holding History

Chelsea Counsel Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-35	Closed	-$2.52K	–	155
2022 Q4	$2.52K	Buy	+35	New	+$2.64K	﹤0.01%	157
2022 Q3	–	Sell	-4,063	Closed	-$313K	–	86
2022 Q2	$313K	Hold	4,063	–	–	0.16%	84
2022 Q1	$297K	Hold	4,063	–	–	0.13%	84
2021 Q4	$253K	Hold	4,063	–	–	0.11%	86
2021 Q3	$240K	Hold	4,063	–	–	0.11%	89
2021 Q2	$271K	Hold	4,063	–	–	0.12%	80
2021 Q1	$256K	Hold	4,063	–	–	0.13%	81
2020 Q4	$252K	Sell	4,063 -352	-8%	-$21.6K	0.13%	77
2020 Q3	$266K	Buy	4,415 +141	+3%	+$8.49K	0.16%	69
2020 Q2	$251K	Buy	+4,274	New	+$256K	0.15%	68
2019 Q3	–	Sell	-4,518	Closed	-$205K	–	70
2019 Q2	$205K	Hold	4,518	–	–	0.11%	74
2019 Q1	$216K	Buy	+4,518	New	+$225K	0.12%	71
2017 Q4	–	Sell	-3,363	Closed	-$214K	–	85
2017 Q3	$214K	Buy	+3,363	New	+$196K	0.11%	76
2016 Q3	–	Sell	-2,835	Closed	-$209K	–	90
2016 Q2	$209K	Sell	2,835 -500	-15%	-$35.3K	0.09%	91
2016 Q1	$213K	Sell	3,335 -100	-3%	-$6.31K	0.07%	118
2015 Q4	$236K	Sell	3,435 -104	-3%	-$6.87K	0.07%	129
2015 Q3	$210K	Buy	3,539 +35	+1%	+$2.22K	0.05%	147
2015 Q2	$233K	Hold	3,504	–	–	0.05%	142
2015 Q1	$226K	Sell	3,504 -600	-15%	-$37.6K	0.05%	126
2014 Q4	$242K	Hold	4,104	–	–	0.05%	123
2014 Q3	$210K	Buy	+4,104	New	+$205K	0.04%	129
2014 Q2	–	Sell	-6,704	Closed	-$348K	–	127
2014 Q1	$348K	Buy	6,704 +2,600	+63%	+$138K	0.07%	94
2013 Q4	$218K	Buy	+4,104	New	+$209K	0.05%	103

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Chelsea Counsel Company's BMY Position: Q1 2023 in Review

Chelsea Counsel Company sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 35 shares — an estimated $2.52K sold.

Chelsea Counsel Company first reported a position in BMY in Q4 2013 and held it in 23 quarters. The position peaked at $348K in Q1 2014. 2,541 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

Chelsea Counsel Company reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
Chelsea Counsel Company sold 35 Bristol-Myers Squibb shares in Q1 2023, an estimated $2.52K.
Chelsea Counsel Company first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 23 quarters.
Chelsea Counsel Company's Bristol-Myers Squibb position peaked at $348K in Q1 2014.
2,541 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Chelsea Counsel Company's 13F filing for Q1 2023, filed 19 May 2023.